PR
Media
-
HEM Pharma and Amway Japan Host “One & Only Microbiome Lab”2026.07.08 -
HEM Pharma Participates in IPC 2026, Expanding Global Collaboration in Microbiom..2026.07.08 -
HEM Pharma Reinforces Executive Team with Former Eugene Investment & Securities ..2026.07.08 -
HEM Pharma CEO Joseph Ji: "Integrated Data, Manufacturing, and Commercializ..2026.06.29 -
"A One-Million-Case Database Will Revive Stagnant Microbiome Clinical Resea..2026.06.29 -
HEM Pharma Wins First Global Amway Probiotics Order, Full Production at Sejong F..2026.06.29 -
HEM Pharma Removes CB Refixing Clause, Clearing Up Q1 Accounting Distortion2026.06.29 -
HEM Pharma and Autocrypt Partner on Vignal Security Initiative, Targeting 1 Mill..2026.06.11 -
HEM Pharma Discovers Novel Probiotic Strain That Inhibits Vaginitis-Causing Bact..2026.05.19 -
Another Major Deal Just 79 Days Later: HEM Pharma Proves Its Ability to Generate..2026.05.16 -
HEM Pharma Secures 90,000 Orders Ahead of Japan Launch, Exceeding Annual Sales V..2026.05.15 -
HEM Pharma CEO Joseph Ji: “Strong Momentum in Japan Supports Confidence in Q3 Pr..2026.05.12
- Headquarters
-
Address. #711, Flex Desiang, 50, Changnyong-daero 256beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
- Sejong Factory
- Address. 80, Sojeongsandan 6-ro, Sojeong-myeon, Sejong-si, Republic of Korea
(C) 2022.HEM Pharma Inc. All rights reserved.